53Biologics Is Heading To BIO International Convention 2025
10 Jun 2025 //
PRESS RELEASE
The Strategic Value Of A CDMO In The Pharmaceutical Industry
21 May 2025 //
PRESS RELEASE
Large?Scale Protein Manufacturing Key Considerations
06 May 2025 //
PRESS RELEASE
Applications Of pDNA In Biotechnology And Medicine
30 Apr 2025 //
PRESS RELEASE
Differences Between Research, Master And Working Cell Banks
21 Apr 2025 //
PRESS RELEASE
How To Reduce Costs In Your Biologics Production Process
08 Apr 2025 //
PRESS RELEASE
53Biologics Awarded Best Biotech Innovation at Farmaforum
26 Sep 2024 //
PRESS RELEASE
Recognized As Europe’s Leading CDMO for Biologics Production
15 Aug 2024 //
PRESS RELEASE
53Biologics is finalist for the Biotechforum award
24 Jul 2024 //
PRESS RELEASE
Safety First at 53Biologics
12 Jun 2024 //
PRESS RELEASE
53Biologics Unveils New GMP Production Line for Biologics
10 May 2023 //
CONTRACT PHARMA
53Biologics expands its state-of-the-art facilities to better serve biopharma industry
28 Apr 2023 //
PRESS RELEASE
Introducing 53Biologics’ New 2000L GMP Production Line for Biologics
28 Apr 2023 //
PRESS RELEASE
53Biologics Awarded ISO 13485 Certification for Quality Management System
20 Mar 2023 //
PRESS RELEASE
53Biologics Expands its State-of-the-art Facilities
17 Mar 2023 //
CONTRACT PHARMA